U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 12b-25
NOTIFICATION OF LATE FILING
[X] FORM 10-KSB for period ending 4/30/98
Part I - Registrant Information
Full Name of Registrant: American Bio Medica Corporation
Former name if applicable: Not applicable
Address of Principal Executive Office: 300 Fairview Avenue
Hudson, New York 12534
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense
Part III - Narrative
State below in reasonable detail the reasons why Form 10-KSB could not be
filed within the prescribed period:
The subject form 10-KSB cannot be timely filed without unreasonable effort
or expense because of a delay by the Company's new auditors in receiving
confirmations of financial information.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
John F. Murray, Chief Financial Officer 800-227-1243
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such reports been filed: If the answer is
no, identify report. [X] Yes
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? [X] No
Date: July 28, 1998 American Bio Medica Corporation
By: /s/Stan Cipkowski
-------------------
Stan Cipkowski,
President
